- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
瑞舒伐他汀钙治疗血管性痴呆61例临床分析
瑞舒伐他汀钙治疗血管性痴呆61例临床分析
[摘要] 目的 探讨瑞舒伐他汀钙治疗血管性痴呆的疗效。 方法 将我院2012年12月~2013年8月收治的61例血管性痴呆患者随机分为三组,A组予常规治疗,B组在常规治疗基础上加用安理申,C组在常规治疗基础上加用瑞舒伐他汀钙,观察三组的治疗效果。 结果 安理申组有效率优于常规治疗组,瑞舒伐他汀钙组有效率优于常规治疗组,三组治疗后MoCA评分比较有统计学差异(P0.05);B、C组患者治疗后MoCA评分较治疗前有一定改善,差异有统计学意义(P0.05)。 结论 临床中对轻中度血管性痴呆患者采取安理申治疗具有一定效果,瑞舒伐他汀钙通过调节血脂改善血流循环降低脑血管事件的发生,从而延缓脑血管性痴呆的进程,提高认知功能,具有重要应用价值。
[关键词] 血管性痴呆;安理申;瑞舒伐他汀钙;MoCA
Clinical analysis of rosuvastatin calcium tablets in treatment of 61 cases of vascular dementia
LIU Fang1 TANG Yong2 REN Anji3
1.Weifang Medical University Graduate School,Weifang 261053, China;2.Department of the 3rd Health Care, Weifang Peoples Hospital the Third Department of Health,Weifang 261041, China; 3.Department of Urology, Weifang Traditional Chinese Hospital,Weifang 261041, China
[Abstract] Objective To explore the effect of rosuvastatin calcium tablets in treatment of vascular dementia. Methods A total of 61 vascular dementia patients that treated in our hospital from 2012.12 to 2013.08 were randomly divided into three groups,group A of conventional therapy,group B applies Aricept on the basis of conventional therapy,group C applied rosuvastatin conventional statin based on calcium,then observed the treatment effect of three groups. Results Aricept group was superior to the conventional treatment group,rosuvastatin calcium group was superior to the conventional treatment group,MoCA scores between the three groups after treatment were statistically significant(P0.05); Group B and group C of patients after treatment MoCA pre-treatment score had a certain improvement compared with those before treatment,the difference was statistically significant(P0.05). Conclusion Clinical taken on mild to moderate vascular dementia Aricept therapy has a certain effect,rosuvastatin calcium to improve blood circulation by regulating blood lipids reduce the incidence of cerebrovascular events,thus delaying the process of cerebrovascular dementia,raise awareness function, has important applicat
文档评论(0)